A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia
Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-017-0550-8
Full Text
Open PDFAbstract
Available in full text
Date
January 5, 2018
Authors
Publisher
Springer Science and Business Media LLC